CAM

Cormorant Asset Management Portfolio holdings

AUM $1.34B
This Quarter Return
-17.65%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$1.32B
AUM Growth
+$1.32B
Cap. Flow
-$75.9M
Cap. Flow %
-5.74%
Top 10 Hldgs %
65.22%
Holding
52
New
4
Increased
6
Reduced
13
Closed
10

Top Buys

1
GHRS icon
GH Research
GHRS
$15.6M
2
EWTX icon
Edgewise Therapeutics
EWTX
$15.3M
3
SPRY icon
ARS Pharmaceuticals
SPRY
$13.8M
4
BBIO icon
BridgeBio Pharma
BBIO
$13.8M
5
MTSR
Metsera, Inc. Common Stock
MTSR
$10.9M

Top Sells

1
RNA icon
Avidity Biosciences
RNA
$19.2M
2
ACLX icon
Arcellx
ACLX
$16.4M
3
AVBP icon
ArriVent BioPharma
AVBP
$15.6M
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
$13.4M
5
RYTM icon
Rhythm Pharmaceuticals
RYTM
$13.2M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CRBP icon
26
Corbus Pharmaceuticals
CRBP
$121M
$12.6M 0.95%
2,375,000
– –
RNA icon
27
Avidity Biosciences
RNA
$6.11B
$11.8M 0.89%
400,000
-650,000
-62% -$19.2M
MTSR
28
Metsera, Inc. Common Stock
MTSR
$3.75B
$10.9M 0.82%
+400,000
New +$10.9M
ENGN icon
29
enGene Holdings
ENGN
$234M
$10.4M 0.78%
2,323,595
– –
BIOA
30
BioAge Labs, Inc. Common Stock
BIOA
$168M
$9.89M 0.74%
2,629,529
– –
RYTM icon
31
Rhythm Pharmaceuticals
RYTM
$6.78B
$7.95M 0.6%
150,000
-250,000
-63% -$13.2M
OKUR
32
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$38.6M
$7.9M 0.59%
1,837,739
– –
BMEA icon
33
Biomea Fusion
BMEA
$115M
$7.61M 0.57%
3,570,872
– –
KRRO icon
34
Korro Bio
KRRO
$239M
$6.62M 0.5%
+380,303
New +$6.62M
PCVX icon
35
Vaxcyte
PCVX
$4.12B
$6.61M 0.5%
175,000
-250,000
-59% -$9.44M
AARD
36
Aardvark Therapeutics, Inc. Common Stock
AARD
$177M
$6.01M 0.45%
+800,189
New +$6.01M
MBX
37
MBX Biosciences, Inc. Common Stock
MBX
$488M
$5.17M 0.39%
700,000
– –
ELVN icon
38
Enliven Therapeutics
ELVN
$1.24B
$4.92M 0.37%
250,000
– –
PLRX icon
39
Pliant Therapeutics
PLRX
$104M
$4.05M 0.3%
+3,000,000
New +$4.05M
KALA icon
40
KALA BIO
KALA
$101M
$3.46M 0.26%
603,027
– –
STOK icon
41
Stoke Therapeutics
STOK
$1.08B
$1.69M 0.13%
254,161
– –
BHVN icon
42
Biohaven
BHVN
$1.7B
$240K 0.02%
10,000
-45,539
-82% -$1.09M
SEPN
43
Septerna, Inc. Common Stock
SEPN
$629M
– –
-560,000
Closed -$12.8M
IBRX icon
44
ImmunityBio
IBRX
$2.24B
– –
-3,000,000
Closed -$7.68M
OMER icon
45
Omeros
OMER
$280M
– –
-300,000
Closed -$2.96M
RAPT icon
46
RAPT Therapeutics
RAPT
$188M
– –
-200,000
Closed -$316K
URGN icon
47
UroGen Pharma
URGN
$891M
– –
-300,000
Closed -$3.2M
VERV
48
DELISTED
Verve Therapeutics
VERV
– –
-350,000
Closed -$1.97M
VYNE icon
49
VYNE Therapeutics
VYNE
$8.06M
– –
-1,394,336
Closed -$4.67M
YMAB icon
50
Y-mAbs Therapeutics
YMAB
$389M
– –
-425,000
Closed -$3.33M
1
2
3